Drugs Archives - Page 39 of 66

Podcast

KHN’s ‘What The Health?’: Deciphering The Democrats’ Health Debate

Health care was a major topic at the Democratic presidential candidate debates in Detroit on Tuesday and Wednesday, but the focus on plan minutiae may have left viewers more confused than edified. Alice Ollstein of Politico, Kimberly Leonard of the Washington Examiner and Caitlin Owens of Axios join KHN’s Julie Rovner to discuss the points made by the candidates plus a series of Trump administration health initiatives on drug prices and hospital shopping.

Aug. 1, 2019

California Bill Would Fight Deals That Delay Generic Drugs

As California Attorney General Xavier Becerra cracks down on pharmaceutical companies he said paid competitors to delay generic versions of their drugs, he’s also pushing for legislation that would give his department tools to catch more of them. It’s the first of its kind in the nation.

By Ana B. Ibarra

Aug. 1, 2019

Trump Administration ‘Open For Business’ On Drug Imports From Canada

HHS secretary announces a preliminary plan Wednesday to allow Americans to import certain lower-cost drugs from Canada. Manufacturers were quick to criticize the plan, saying it does not guarantee the safety of drugs coming into the country.

By Phil Galewitz

July 31, 2019

Trump Administration Moves To Make Health Care Costs More Transparent

The proposed rules would require hospitals to provide far more detail about the actual prices they charge insurers for patients’ care.

By Julie Appleby

July 31, 2019

New Protocol For HIV Prevention Drug Reduces The Number Of Pills Required

Health officials and AIDS advocates in San Francisco have endorsed a new regimen for PrEP medication: to be taken only immediately before and after sex, thus reducing cost and potential side effects. The standard regimen is one pill a day for an open-ended period.

By David Tuller

July 29, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

July 26, 2019

KHN & PolitiFact HealthCheck

Klobuchar Says D.C. Has Enough Drug Lobbyists To Double-Team Lawmakers

The drug industry has the biggest lobbying war chest.

By Julie Appleby

July 26, 2019

GOP Senators Distance Themselves From Grassley And Trump’s Efforts To Cut Drug Prices

Even some Republicans who supported a sweeping bipartisan bill to rein in drug costs may not back it in the Senate vote.

By Emmarie Huetteman

July 25, 2019

Podcast

KHN’s ‘What The Health?’: Cue The Drug Price Debate

Democrats and Republicans on the Senate Finance Committee unveiled their long-awaited proposal to try to rein in prescription drug costs, even as bipartisan leaders of the other Senate committee that oversees health announced it would not bring its drug price bill to the Senate floor until fall. Paige Winfield Cunningham of The Washington Post, Rebecca Adams of CQ Roll Call and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus court actions on health issues.

July 25, 2019

Summer Setbacks: The Long Road To Lower Drug Prices Hits Some Potholes

Efforts to control drug prices seemed on a glide path earlier this year after gaining traction at the White House and in Congress. But prospects today look less certain and highly controversial.

By Emmarie Huetteman

July 24, 2019

KHN & PolitiFact HealthCheck

A Conservative Group Paints Trump’s Drug-Pricing Experiment As ‘Socialist.’ Is It?

The Americans for Tax Reform commercial takes too broad a brush against an initiative under consideration by the administration that would be part of the president’s promise to curb high drug prices.

By Shefali Luthra

July 22, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

July 19, 2019

Podcast

KHN’s ‘What The Health?’: Biden Doubles Down On Obamacare

Presidential candidate Joe Biden unveiled a health plan intended to provide a more moderate alternative to his competitors’ “Medicare for All” plans. It would build on the Affordable Care Act but would go much further. Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss this, plus Planned Parenthood’s very bad week, the U.S. House vote to repeal the health law’s “Cadillac tax” on generous health plans, and the reduction in deaths from opioids.

July 18, 2019

Letters To The Editor

KHN Investigation On Opioid Prescribers Pains Some Readers And Tweeters

Kaiser Health News gives readers a chance to comment on a recent batch of stories.

July 18, 2019

Navigating Aging

Common Medications Can Masquerade As Dementia In Seniors

A wide variety of medications used to treat allergies, insomnia, leaky bladders, diarrhea, dizziness, motion sickness, asthma, Parkinson’s disease, chronic obstructive pulmonary disease and psychiatric disorders can interfere with cognition in older patients.

By Judith Graham

July 18, 2019

Pain Meds As Public Nuisance? Oklahoma Tests A Legal Strategy Against Opioid Maker

Oklahoma is seeking $17 billion in damages from Johnson & Johnson, the pharmaceutical giant. After a seven-week trial, a judge will decide if the opioid drugmaker is liable and if so, for how much.

By Jackie Fortiér, StateImpact Oklahoma

July 17, 2019

A ‘No-Brainer’? Calls Grow For Medicare To Cover Anti-Rejection Drugs After Kidney Transplant

Banking on new cost estimates, a bipartisan coalition in Congress is poised to try — once again — to end a three-year limit on coverage for lifesaving medication required to keep the organs functioning.

By JoNel Aleccia

July 17, 2019

Even When HIV Prevention Drug Is Covered, Other Costs Block Treatment

The U.S. Preventive Services Task Force recommended that people who are at high risk of contracting HIV take PrEP, a preventive treatment. The decision means most health plans will be required to cover the drugs without charging patients. But the recommendation doesn’t apply to the other clinical and lab services people need.

By Michelle Andrews

July 15, 2019

Must-Reads Of The Week From Brianna Labuskes

Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.

By Brianna Labuskes

July 12, 2019

Podcast

KHN’s ‘What The Health?’: Could The ACA Really Go Away?

Is the entire Affordable Care Act unconstitutional? That was the question before a federal appeals court in New Orleans this week. Two of the three judges on the panel seemed inclined to agree with a lower court that the elimination of the tax penalty for failure to maintain coverage could mean the entire health law should fall. Also this week, President Donald Trump wants to improve care for people with kidney disease. Joanne Kenen of Politico, Kimberly Leonard of the Washington Examiner and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this, plus courts blocking efforts to require drug prices in TV ads and to kick Planned Parenthood out of the federal family planning program. Plus, Rovner interviews University of Michigan law professor Nicholas Bagley about the latest legal threat to the ACA.

July 11, 2019

Trump 2.0

Public Health

Audio Reports

Special Reports

More Topics

Drugs